SLB Ltd
SLB
47.96
-2.04
-4.08%
SLB Ltd
US · SLB
#271 by market cap
Listed 1970
47.96
-2.04
-4.08%
Live - 5344 symbols - heartbeat 524s ago
· 2026-10-08 08:26
Pre-market
48.64
+1.42%
After-hours
48.00
+0.08%
Overnight
48.06
+0.21%
- Market cap
- 71.18B
- P/E (TTM)i
- 23.40
- P/Bi
- 2.73
- EPSi
- 2.35
- Div yieldi
- 2.42%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on SLB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.09, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.60% YoY
Margins
- Gross margin
- 18.22%
- Operating margin
- 15.29%
- Net margin
- 9.45%
Key ratios & quality
- Enterprise valuei
- 78.60B
- Altman Z-Scorei
- 3.09
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.82B | 32.92B | 23.60B | 22.93B | 28.09B | 33.14B | 36.29B | 35.71B |
| Gross profit | 4.34B | 4.20B | 2.60B | 3.66B | 5.16B | 6.56B | 7.46B | 6.51B |
| Selling & admin expenses | 444.00M | 474.00M | 365.00M | 339.00M | 376.00M | 364.00M | 385.00M | 340.00M |
| Research & development | 702.00M | 717.00M | 580.00M | 554.00M | 634.00M | 711.00M | 749.00M | 709.00M |
| Operating profit | 3.19B | 3.01B | 1.66B | 2.77B | 4.15B | 5.49B | 6.33B | 5.46B |
| Pretax profit | 2.62B | -10.42B | -11.30B | 2.37B | 4.27B | 5.28B | 5.67B | 4.29B |
| Tax | 447.00M | -311.00M | -812.00M | 446.00M | 779.00M | 1.01B | 1.09B | 840.00M |
| Net profit | 2.18B | -10.11B | -10.49B | 1.93B | 3.49B | 4.28B | 4.58B | 3.45B |
| Basic EPS | 2 | -7 | -8 | 1 | 2 | 3 | 3 | 2 |
| Diluted EPS | 1.53 | -7.32 | -7.57 | 1.32 | 2.39 | 2.91 | 3.11 | 2.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 8.49B | 8.55B | 8.93B | 9.75B | 8.72B | 8.97B |
| Gross profit | 1.61B | 1.61B | 1.56B | 1.73B | 1.33B | 1.40B |
| Selling & admin expenses | 96.00M | 87.00M | 72.00M | 84.00M | 97.00M | 84.00M |
| Research & development | 172.00M | 180.00M | 170.00M | 187.00M | 164.00M | 171.00M |
| Operating profit | 1.34B | 1.35B | 1.32B | 1.46B | 1.07B | 1.14B |
| Pretax profit | 1.06B | 1.29B | 1.00B | 943.00M | 956.00M | 1.02B |
| Tax | 234.00M | 237.00M | 226.00M | 143.00M | 195.00M | 204.00M |
| Net profit | 829.00M | 1.05B | 774.00M | 800.00M | 761.00M | 815.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.58 | 0.74 | 0.50 | 0.55 | 0.50 | 0.52 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 15.73B | 15.53B | 12.92B | 12.65B | 15.00B | 17.72B | 18.57B | 19.51B |
| Cash & ST investments | 2.78B | 2.17B | 3.01B | 3.14B | 2.89B | 3.99B | 4.67B | 4.21B |
| Inventory | 4.01B | 4.13B | 3.35B | 3.27B | 4.00B | 4.39B | 4.38B | 5.03B |
| Total assets | 70.51B | 56.31B | 42.43B | 41.51B | 43.14B | 47.96B | 48.94B | 54.87B |
| Total current liabilities | 13.49B | 13.10B | 10.49B | 10.36B | 12.02B | 13.40B | 12.81B | 14.72B |
| Short-term debt | 1.41B | 524.00M | 850.00M | 909.00M | 1.63B | 1.12B | 1.05B | 1.89B |
| Long-term debt | 14.64B | 14.77B | 16.04B | 13.29B | 10.59B | 10.84B | 11.02B | 9.74B |
| Total liabilities | 33,921,000,000.00 | 32,136,000,000.00 | 29,945,000,000.00 | 26,225,000,000.00 | 25,146,000,000.00 | 26,598,000,000.00 | 26,585,000,000.00 | 27,577,000,000.00 |
| Total equity | 36.59B | 24.18B | 12.49B | 15.29B | 17.99B | 21.36B | 22.35B | 27.29B |
| Retained earnings | 31.66B | 18.75B | 7.02B | 8.20B | 10.72B | 13.50B | 16.40B | 18.07B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 18.60B | 18.45B | 19.47B | 19.51B | 19.34B | 20.24B |
| Cash & ST investments | 3.90B | 3.75B | 3.59B | 4.21B | 3.39B | 4.07B |
| Inventory | 4.65B | 4.74B | 5.32B | 5.03B | 5.27B | 5.44B |
| Total assets | 49.00B | 48.77B | 55.09B | 54.87B | 54.53B | 55.53B |
| Total current liabilities | 15.04B | 14.04B | 14.04B | 14.72B | 14.41B | 14.07B |
| Short-term debt | 3.48B | 2.81B | 1.92B | 1.89B | 1.94B | 1.66B |
| Long-term debt | 10.53B | 10.89B | 10.84B | 9.74B | 9.67B | 11.14B |
| Total liabilities | 28,254,000,000.00 | 27,218,000,000.00 | 28,171,000,000.00 | 27,577,000,000.00 | 27,173,000,000.00 | 28,278,000,000.00 |
| Total equity | 20.75B | 21.55B | 26.92B | 27.29B | 27.35B | 27.25B |
| Retained earnings | 16.80B | 17.43B | 17.75B | 18.07B | 18.37B | 18.71B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.71B | 5.43B | 2.94B | 4.65B | 3.72B | 6.64B | 6.60B | 6.49B |
| Depreciation & amortization | 3.56B | 3.59B | 2.00B | 1.70B | 1.67B | 1.76B | 1.89B | 2.11B |
| Free cash flow | 3.45B | 3.48B | 1.73B | 3.47B | 2.01B | 4.55B | 4.47B | 4.54B |
| Dividends paid | -2.77B | -2.77B | -1.73B | -699.00M | -848.00M | -1.32B | -1.53B | -1.60B |
| Stock buybacks / issuance | -400.00M | -278.00M | -26.00M | 0 | 0 | -694.00M | -1.74B | -2.41B |
| Ending cash balance | 1.43B | 1.14B | 844.00M | 1.76B | 1.66B | 2.90B | 3.54B | 3.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 660.00M | 1.14B | 1.68B | 3.01B | 487.00M | 1.36B |
| Depreciation & amortization | 640.00M | 633.00M | 638.00M | 198.00M | 685.00M | 712.00M |
| Free cash flow | 211.00M | 822.00M | 1.11B | 2.41B | 80.00M | 964.00M |
| Dividends paid | -386.00M | -387.00M | -403.00M | -426.00M | -426.00M | -440.00M |
| Stock buybacks / issuance | -2.30B | 0 | -114.00M | 0 | -451.00M | -648.00M |
| Ending cash balance | 2.94B | 3.24B | 3.01B | 3.04B | 2.82B | 2.74B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.86 | -33.83 | -58.71 | 13.89 | 21.05 | 22.19 | 21.59 | 14.28 |
| ROA %i | 3.00 | -15.99 | -21.30 | 4.48 | 8.13 | 9.23 | 9.21 | 6.50 |
| ROIC %i | 4.78 | -21.01 | -29.48 | 7.88 | 12.73 | 14.60 | 14.49 | 10.47 |
| 5-year avg ROE %i | 3.46 | -6.12 | -18.99 | -15.33 | -10.35 | -7.08 | 4.01 | 18.60 |
| EBIT margin %i | 9.75 | -29.80 | -45.49 | 12.70 | 16.95 | 17.46 | 17.04 | 13.58 |
| FCF / sales %i | 10.52 | 10.56 | 7.32 | 15.14 | 7.14 | 13.72 | 12.33 | 12.72 |
| Current ratioi | 1.17 | 1.19 | 1.23 | 1.22 | 1.25 | 1.32 | 1.45 | 1.33 |
| Quick ratioi | 0.79 | 0.76 | 0.79 | 0.82 | 0.80 | 0.88 | 0.99 | 0.88 |
| Debt / assetsi | 22.77 | 27.16 | 39.79 | 34.20 | 28.34 | 24.95 | 24.67 | 21.21 |
| LT debt / equityi | 40.50 | 62.16 | 132.85 | 88.55 | 59.90 | 53.70 | 52.17 | 37.31 |
| Interest coveragei | 5.56 | -16.11 | -19.07 | 5.40 | 9.72 | 11.50 | 12.08 | 8.69 |
| Revenue CAGR (3Y) %i | -2.56 | 5.78 | -8.13 | -11.26 | -5.15 | 11.97 | 16.54 | 8.33 |
| Net income CAGR (3Y) %i | 1.05 | -- | -- | -4.18 | -- | -- | 33.36 | -0.65 |
| FCF CAGR (3Y) %i | -16.40 | -0.94 | -19.25 | 0.17 | -16.76 | 38.06 | 8.82 | 31.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 20.82 | 19.78 | 15.46 | 14.28 | 14.57 | 13.37 |
| ROA %i | 8.65 | 8.34 | 6.95 | 6.50 | 6.43 | 5.95 |
| ROIC %i | 13.52 | 12.91 | 10.91 | 10.47 | 10.25 | 9.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.42 | 16.34 | 15.03 | 13.58 | 13.11 | 12.18 |
| FCF / sales %i | 13.27 | 12.98 | 10.96 | 12.72 | 12.28 | 12.52 |
| Current ratioi | 1.24 | 1.31 | 1.39 | 1.33 | 1.34 | 1.44 |
| Quick ratioi | 0.83 | 0.88 | 0.90 | 0.88 | 0.86 | 0.94 |
| Debt / assetsi | 28.57 | 28.09 | 23.17 | 21.21 | 21.29 | 23.05 |
| LT debt / equityi | 53.94 | 53.65 | 42.30 | 37.31 | 36.94 | 42.72 |
| Interest coveragei | 10.85 | 10.43 | 9.41 | 8.69 | 8.94 | 8.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Production Systems is the largest reported line at 42.03% of revenue, across 6 reported segments.
- No single line clears half of revenue; Well Construction is next at 30.56%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Production Systems42.03%
Well Construction30.56%
Reservoir Performance17.34%
Digital7.77%
All other5.63%
Quote time 2026-10-08 08:26:46 · For reference only, not investment advice and not tailored to your situation.